Peterlabs Holdings BhdXKLS:0171 +2.13%47 Gross Margin % is 1.06% as of Jun. 2025, which is 94% below its 10-year median of 18.84. GuruFocus rates XKLS:0171 with a GF Score™ of 47/100 and a GF Value™ of RM0.20 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 935 Drug Manufacturers companies, Peterlabs Holdings Bhd ranks worse than 95.19% on this metric.
XKLS:0171's Gross Margin % is ranked worse than 95.19% of 935
companies
in the Drug Manufacturers industry
Industry Median: 48.54
vs XKLS:0171: 11.12
Peterlabs Holdings Bhd had a gross margin of 1.06% for the quarter that ended in Jun. 2025 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Peterlabs Holdings Bhd was -10.20% per year.
Peterlabs Holdings Bhd (XKLS:0171) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Peterlabs Holdings Bhd had a gross margin of 1.06% for the quarter that ended in Jun. 2025 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Peterlabs Holdings Bhd Gross Margin % Related Terms
Peterlabs Holdings Bhd Gross Margin % Historical Data
* Premium members only.
The historical data trend for Peterlabs Holdings Bhd's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:0171 vs ZTS, UTHR, VTRS: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Peterlabs Holdings Bhd's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Peterlabs Holdings Bhd Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Peterlabs Holdings Bhd's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Peterlabs Holdings Bhd's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Peterlabs Holdings Bhd (XKLS:0171) has a Gross Margin % of 1.06% as of Jun. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Peterlabs Holdings Bhd and its competitors. This is 94% below median its historical median of 18.84. Over the past decade, Peterlabs Holdings Bhd's Gross Margin % has ranged from 11.12 to 22.44. According to the industry distribution chart, Peterlabs Holdings Bhd ranks #890 out of 935 companies in the Drug Manufacturers industry, placing it in the top 95.2%.
Is Peterlabs Holdings Bhd's Gross Margin % too high?
Peterlabs Holdings Bhd's current Gross Margin % of 1.06% is 94% below median its 10-year median of 18.84. Over the past 10 years, this metric has ranged from a low of 11.12 to a high of 22.44. The Drug Manufacturers industry median Gross Margin % is 48.54. Peterlabs Holdings Bhd's value of 1.06% is 97.8% below this industry median. Based on the distribution chart, Peterlabs Holdings Bhd ranks #890 out of 935 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Peterlabs Holdings Bhd has a GF Score™ of 47/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Peterlabs Holdings Bhd's Gross Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Peterlabs Holdings Bhd ranks #890 out of 935 companies for Gross Margin %. This places Peterlabs Holdings Bhd in the lower half of its industry. The industry median Gross Margin % is 48.54. Peterlabs Holdings Bhd's value of 1.06% is 97.8% below this benchmark. Historically, Peterlabs Holdings Bhd's own Gross Margin % has ranged from 11.12 to 22.44 over the past decade. While the company's 10-year median is 18.84 vs. the industry median of 48.54, Peterlabs Holdings Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 935 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Peterlabs Holdings Bhd's current Gross Margin % of 1.06% is 97.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Peterlabs Holdings Bhd and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Peterlabs Holdings Bhd's current Gross Margin % is 1.06%, which is 94% below median its own 10-year median of 18.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Peterlabs Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Peterlabs Holdings Bhd (XKLS:0171) is currently considered Modestly Overvalued. The stock's GF Value™ is RM0.20, compared to a current price of RM0.24 — trading 20% above its estimated fair value. The current Gross Margin % is 1.06%, which is 94% below median its 10-year median of 18.84 and 97.8% below the Drug Manufacturers industry median of 48.54. Peterlabs Holdings Bhd's overall GF Score™ is 47/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Peterlabs Holdings Bhd (XKLS:0171), the current Gross Margin % is 1.06% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Peterlabs Holdings Bhd (XKLS:0171) Overvalued in 2026?
Based on GuruFocus' analysis, Peterlabs Holdings Bhd stock appears to be overvalued.
The current stock price of RM0.24 is trading 20% above its estimated GF Value™ of RM0.20.
GuruFocus considers Peterlabs Holdings Bhd to be Modestly Overvalued.
Key valuation signals for XKLS:0171:
Gross Margin %: 1.06% (94% below median its 10-year median of 18.84)
GF Value™: RM0.20 vs. price of RM0.24 (20% above fair value)
Industry Position: 97.8% below the Drug Manufacturers median (#890 of 935)
No single metric tells the full story. See the XKLS:0171 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Peterlabs Holdings Bhd is engaged in the manufacturing, distribution, export, and trading of animal health and nutrition products. The Group offers biosecurity and disinfectants, compound feed supplements, feed additives, nutritional premixes, pharmaceuticals, and water-soluble supplements, as well as farm management, technical advisory services, raw material analysis, and feed formulation. Its segments are Manufacturing, which covers the manufacturing and distribution of animal health and nutrition products; Trading, which involves the trading and distribution of animal health and nutrition products and consumer goods, and contributes the majority of its revenue; and Others, which provides investment holding services. The company operates in Malaysia and internationally.
47GF Score
Get the complete analysis for XKLS:0171
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0171 has been successfully added to your 
